DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Nauck M, Weinstock RS, Umpierrez GE et al.
Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5).
Diabetes Care 2014;
37: 2149-2158
Access:
We do not assume any responsibility for the contents of the web pages of other providers.